Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography
Recruiting · NCT06386185 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
ElectrocardiogramRight heart catheterTransthoracic echocardiogram
What this trial is about
The goal of this observational study is to assess the efficacy that the addition of novel markers cardiac function, particularly of right ventricular (RV) function in echocardiography, and ECG have in detecting pulmonary hypertension. The main questions it aims to answer are: Can novel markers in ECG and echocardiography suggest the presence of PH? Can existing screening guidelines be improved with the addition of these markers?
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients 18+ who have undergone TTE, ECG and RHC as part of their clinical care
Exclusion criteria
- Patients \<18 years old
- Known or suspected congenital heart disease
- Patient has opted-out of allowing their data to be used for research and planning (via the national data opt-out choice in England, or equivalent data protection scheme in Scotland)
Where it is running
5 locations listed.
- Royal Papworth Hospital - Cambridge, United Kingdom
- Royal Free NHS Foundation Trust - London, United Kingdom
- Royal United Hospital NHS Foundation Trust - Bath, Banes, United Kingdom
- Golden Jubilee Hospital - Glasgow, Lanarkshire, United Kingdom
- Sheffield Teaching Hospitals NHS Foundation Trust - Sheffield, South Yorkshire, United Kingdom